Bristol Myers Squibb (BMYMP) Amortization - Intangibles (2019 - 2025)
Historic Amortization - Intangibles for Bristol Myers Squibb (BMYMP) over the last 7 years, with Q4 2025 value amounting to $826.0 million.
- Bristol Myers Squibb's Amortization - Intangibles fell 5121.09% to $826.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year decrease of 6261.27%. This contributed to the annual value of $3.3 billion for FY2025, which is 6261.27% down from last year.
- Per Bristol Myers Squibb's latest filing, its Amortization - Intangibles stood at $826.0 million for Q4 2025, which was down 5121.09% from $831.0 million recorded in Q3 2025.
- In the past 5 years, Bristol Myers Squibb's Amortization - Intangibles registered a high of $2.5 billion during Q2 2021, and its lowest value of $826.0 million during Q4 2025.
- For the 5-year period, Bristol Myers Squibb's Amortization - Intangibles averaged around $2.0 billion, with its median value being $2.4 billion (2022).
- As far as peak fluctuations go, Bristol Myers Squibb's Amortization - Intangibles surged by 1012.27% in 2021, and later plummeted by 6564.57% in 2025.
- Quarter analysis of 5 years shows Bristol Myers Squibb's Amortization - Intangibles stood at $2.4 billion in 2021, then dropped by 3.06% to $2.3 billion in 2022, then dropped by 2.77% to $2.3 billion in 2023, then dropped by 25.68% to $1.7 billion in 2024, then crashed by 51.21% to $826.0 million in 2025.
- Its last three reported values are $826.0 million in Q4 2025, $831.0 million for Q3 2025, and $830.0 million during Q2 2025.